WBA
69
26
CHD
24
-2
JBHT
48
-2
ADP
62
-4
AZO
52
-4
ILMN
38
-2
CPB
22
-2
TRIP
57
-13
SPG
43
-2
PBI
32
-3
TMO
59
-3
DOV
46
-3
SHW
33
-3
CTSH
49
3
HIG
44
-6
APH
52
-7
DNB
60
-8
FCX
40
-3
HBAN
39
-9
PNC
44
-8
WBA
69
26
CHD
24
-2
JBHT
48
-2
ADP
62
-4
AZO
52
-4
ILMN
38
-2
CPB
22
-2
TRIP
57
-13
SPG
43
-2
PBI
32
-3
TMO
59
-3
DOV
46
-3
SHW
33
-3
CTSH
49
3
HIG
44
-6
APH
52
-7
DNB
60
-8
FCX
40
-3
HBAN
39
-9
PNC
44
-8
Financhill
Back

T Rowe Price Ultra Short-Term Bond ETF Vs. Intra-Cellular Therapies Industry Stock Comparison

Sell
12

TBUX
T Rowe Price Ultra Short-Term Bond ETF

Last Price:
$49.64
Seasonality Move:
-0.16%
Sell
42

ITCI
Intra-Cellular Therapies

Last Price:
$94.86
Seasonality Move:
2.9%
Sell
12
T Rowe Price Ultra Short-Term Bond ETF (TBUX) is a Sell

Is T Rowe Price Ultra Short-Term Bond ETF a Buy, Sell or Hold?

  • The current T Rowe Price Ultra Short-Term Bond ETF [TBUX] share price is $49.66. The Score for TBUX is 12, which is 76% below its historic median score of 50, and infers higher risk than normal.
  • TBUX is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
42
Intra-Cellular Therapies (ITCI) is a Sell

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $94.87. The Score for ITCI is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • ITCI is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

TBUX Stock Price Chart

What is T Rowe Price Ultra Short-Term Bond ETF's stock price today?

  • The T Rowe Price Ultra Short-Term Bond ETF share price today is $49.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and TBUX is experiencing selling pressure, which indicates risk of future bearish movement.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $94.87
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing slight buying pressure.

TBUX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 48.23 Sell
Chaikin Money Flow: -105643 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.61 - 49.81) Sell
Bollinger Bands (100): (49.68 - 49.86) Sell

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.52 Buy
Relative Strength Index (14 RSI): 71.02 Buy
Chaikin Money Flow: 1717350 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (82.26 - 87.1) Buy
Bollinger Bands (100): (74.04 - 85.96) Buy

TBUX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 49.62 Buy
20-day SMA: 49.7 Sell
50-day SMA: 49.72 Sell
200-day SMA: 49.63 Buy
8-day EMA: 49.65 Buy
20-day EMA: 49.68 Sell
50-day EMA: 49.72 Sell
200-day EMA: 49.61 Buy

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 84.68 Buy
20-day SMA: 84.71 Buy
50-day SMA: 85.48 Buy
200-day SMA: 75.72 Buy
8-day EMA: 85.91 Buy
20-day EMA: 85.03 Buy
50-day EMA: 83.75 Buy
200-day EMA: 76.64 Buy

T Rowe Price Ultra Short-Term Bond ETF Earnings Growth & TBUX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.92 per share, and an increase next year of $3.25 per share.

T Rowe Price Ultra Short-Term Bond ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):